Alpine Immune Sciences Inc (NAS:ALPN)
$ 64.94 0.12 (0.19%) Market Cap: 4.45 Bil Enterprise Value: 4.16 Bil PE Ratio: 0 PB Ratio: 11.95 GF Score: 61/100

Q4 2022 Alpine Immune Sciences Inc Earnings Call Transcript

Mar 23, 2023 / 08:30PM GMT
Release Date Price: $8.12 (+2.65%)
Operator

Welcome to the Alpine Immune Sciences fourth-quarter 2022 earnings call. (Operator Instructions) As a reminder, this event is being recorded.

I would now like to introduce Temre Johnson, Senior Director of Investor Relations and Corporate Communications at Alpine. Ms. Johnson, I'll now turn the call over to you.

Temre Johnson
Alpine Immune Sciences, Inc. - Senior Director IR & Corporate Communications

Thank you, Terri. Good afternoon and thank you for joining us. With me on the call today are Dr. Mitchell Gold, Executive Chairman and Chief Executive Officer; Dr. Stanford Peng, President and Head of Research and Development; and Paul Rickey, Chief Financial Officer.

Before I turn the call over to Mitch, I would like to remind you that we'll be making forward-looking statements during today's call. These forward-looking statements are based on our current expectations and inherently involve significant risk and uncertainty. Actual results and the timing of events, potential publications of clinical data, and expectations regarding the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot